|
Originally published In Press as doi:10.1074/jbc.M300939200 on March 14, 2003
J. Biol. Chem., Vol. 278, Issue 21, 18902-18913, May 23, 2003
Growth Hormone-induced Phosphorylation of Epidermal Growth Factor (EGF) Receptor in 3T3-F442A Cells
MODULATION OF EGF-INDUCED TRAFFICKING AND SIGNALING*
Yao Huang ,
Sung-Oh Kim ,
Jing Jiang and
Stuart J. Frank ¶
From the
Department of Medicine, Division of Endocrinology and Metabolism and Department of Cell Biology, University of Alabama at Birmingham, Birmingham, Alabama 35294,
Endocrinology Section, Medical Service, Veterans Affairs Medical Center, Birmingham, Alabama 35294
Growth hormone (GH) promotes signaling by causing activation of the non-receptor tyrosine kinase, JAK2, which associates with the GH receptor. GH causes phosphorylation of epidermal growth factor receptor (EGFR; ErbB-1) and its family member, ErbB-2. For EGFR, JAK2-mediated GH-induced tyrosine phosphorylation may allow EGFR to serve as a scaffold for GH signaling. For ErbB-2, GH induces serine/threonine phosphorylation that dampens basal and EGF-induced ErbB-2 kinase activation. We now further explore GH-induced EGFR phosphorylation in 3T3-F442A, a preadipocytic fibroblast cell line that expresses endogenous GH receptor, EGFR, and ErbB-2. Using a monoclonal antibody that recognizes ERK consensus site phosphorylation (PTP101), we found that GH caused PTP101-reactive phosphorylation of EGFR. This GH-induced EGFR phosphorylation was prevented by MEK1 inhibitors but not by a protein kinase C inhibitor. Although GH did not discernibly affect EGF-induced EGFR tyrosine phosphorylation, we observed by immunoblotting a substantial decrease of EGF-induced EGFR degradation in the presence of GH. Fluorescence microscopy studies indicated that EGF-induced intracellular redistribution of an EGFR-cyan fluorescent protein chimera was markedly reduced by GH cotreatment, in support of the immunoblotting results. Notably, protection from EGF-induced degradation and inhibition of EGF-induced intracellular redistribution afforded by GH were both prevented by a MEK1 inhibitor, suggesting a role for GH-induced ERK activation in regulating the trafficking itinerary of the EGF-stimulated EGFR. Finally, we observed augmentation of early aspects of EGF signaling (EGF-induced ERK2 activation and EGF-induced Cbl tyrosine phosphorylation) by GH cotreatment; the GH effect on EGF-induced Cbl tyrosine phosphorylation was also prevented by MEK1 inhibition. These data indicate that GH, by activating ERKs, can modulate EGF-induced EGFR trafficking and signaling and expand our understanding of mechanisms of cross-talk between the GH and EGF signaling systems.
Received for publication, January 28, 2003
, and in revised form, March 13, 2003.
¶ To whom correspondence should be addressed: University of Alabama at Birmingham, 1530 3rd Ave. S., BDB 861, Birmingham, AL 35294-0012. Tel.: 205-934-9877; Fax: 205-934-4389; E-mail: frank{at}endo.dom.uab.edu.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
X. Wang, N. Yang, L. Deng, X. Li, J. Jiang, Y. Gan, and S. J. Frank
Interruption of Growth Hormone Signaling via SHC and ERK in 3T3-F442A Preadipocytes upon Knockdown of Insulin Receptor Substrate-1
Mol. Endocrinol.,
April 1, 2009;
23(4):
486 - 496.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Ma, D. Zhang, H. Yang, H. Sun, W. Wu, Y. Gan, J. Balducci, Y.-q. Wei, X. Zhao, and Y. Huang
Endothelial cell-specific molecule 2 (ECSM2) modulates actin remodeling and epidermal growth factor receptor signaling.
Genes Cells,
March 1, 2009;
14(3):
281 - 293.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. La Merrill, D. S. Baston, M. S. Denison, L. S. Birnbaum, D. Pomp, and D. W. Threadgill
Mouse breast cancer model-dependent changes in metabolic syndrome-associated phenotypes caused by maternal dioxin exposure and dietary fat
Am J Physiol Endocrinol Metab,
January 1, 2009;
296(1):
E203 - E210.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Liu, J. Zhang, J. Zhang, S. Liu, Y. Liu, and D. Zheng
Erbin-regulated Sensitivity of MCF-7 Breast Cancer Cells to TRAIL via ErbB2/AKT/NF-{kappa}B Pathway
J. Biochem.,
June 1, 2008;
143(6):
793 - 801.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Frank, X. Wang, K. He, N. Yang, P. Fang, R. G. Rosenfeld, V. Hwa, T. R. Chaudhuri, L. Deng, and K. R. Zinn
In Vivo Imaging of Hepatic Growth Hormone Signaling
Mol. Endocrinol.,
November 1, 2006;
20(11):
2819 - 2830.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. A. Watts III, T. George, and D. W. Good
Aldosterone inhibits apical NHE3 and HCO3- absorption via a nongenomic ERK-dependent pathway in medullary thick ascending limb
Am J Physiol Renal Physiol,
November 1, 2006;
291(5):
F1005 - F1013.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Xu, Z. Liu, T. L. Clemens, and J. L. Messina
Insulin Reverses Growth Hormone-induced Homologous Desensitization
J. Biol. Chem.,
August 4, 2006;
281(31):
21594 - 21606.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Mazurkiewicz-Munoz, L. S. Argetsinger, J.-L. K. Kouadio, A. Stensballe, O. N. Jensen, J. M. Cline, and C. Carter-Su
Phosphorylation of JAK2 at Serine 523: a Negative Regulator of JAK2 That Is Stimulated by Growth Hormone and Epidermal Growth Factor.
Mol. Cell. Biol.,
June 1, 2006;
26(11):
4052 - 4062.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Xu, A. B. Keeton, J. L. Franklin, X. Li, D. Y. Venable, S. J. Frank, and J. L. Messina
Insulin Enhances Growth Hormone Induction of the MEK/ERK Signaling Pathway
J. Biol. Chem.,
January 13, 2006;
281(2):
982 - 992.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. E. Avissar, L. Toia, and H. C. Sax
Epidermal Growth Factor and/or Growth Hormone Induce Differential, Side-Specific Signal Transduction Protein Phosphorylation in Enterocytes
JPEN J Parenter Enteral Nutr,
September 1, 2005;
29(5):
322 - 336.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Mitra, X. Zheng, and M. P. Czech
RNAi-based Analysis of CAP, Cbl, and CrkII Function in the Regulation of GLUT4 by Insulin
J. Biol. Chem.,
September 3, 2004;
279(36):
37431 - 37435.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Huang, Y. Chang, X. Wang, J. Jiang, and S. J. Frank
Growth Hormone Alters Epidermal Growth Factor Receptor Binding Affinity via Activation of Extracellular Signal-Regulated Kinases in 3T3-F442A Cells
Endocrinology,
July 1, 2004;
145(7):
3297 - 3306.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Huang, S.-O. Kim, N. Yang, J. Jiang, and S. J. Frank
Physical and Functional Interaction of Growth Hormone and Insulin-Like Growth Factor-I Signaling Elements
Mol. Endocrinol.,
June 1, 2004;
18(6):
1471 - 1485.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Yang, Y. Huang, J. Jiang, and S. J. Frank
Caveolar and Lipid Raft Localization of the Growth Hormone Receptor and Its Signaling Elements: IMPACT ON GROWTH HORMONE SIGNALING
J. Biol. Chem.,
May 14, 2004;
279(20):
20898 - 20905.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Negro, B. K. Brar, and K.-F. Lee
Essential Roles of Her2/erbB2 in Cardiac Development and Function
Recent Prog. Horm. Res.,
January 1, 2004;
59(1):
1 - 12.
[Abstract]
[Full Text]
|
 |
|
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|